undefined

Christie Ballantyne

Internationally renowned expert on lipids, atherosclerosis, and heart disease prevention. Chief of cardiovascular research and director of cardiometabolic disease prevention at Baylor College of Medicine. Current president of the National Lipid Association.

Top 3 podcasts with Christie Ballantyne

Ranked by the Snipd community
undefined
115 snips
Dec 3, 2024 • 1h 48min

Heart Health Simplified: Expert Tips That Work | Christie Ballantyne M.D

Christie Ballantyne, a leading cardiologist and director at Baylor College of Medicine, discusses vital insights on heart health. She shares how genetics influence heart disease risk and the significant benefits of lifestyle changes. The conversation highlights the importance of personal health assessments, the role of diet in managing cholesterol, and the impact of hormones on cardiovascular wellness. Christie provides practical tips for disease prevention and emphasizes the future of personalized heart health strategies.
undefined
Nov 11, 2024 • 25min

Special Episode- Residual Risk - A Focus on Triglycerides – November 2024

Christie Ballantyne, a renowned cardiologist and director at Baylor College of Medicine, joins Dr. Neil Skolnik to delve into the often-overlooked role of triglycerides in cardiovascular risk. They discuss the limitations of standard treatments like statins and highlight the need for innovative strategies to manage residual risk. The conversation covers the impact of omega-3 fatty acids, the importance of lifestyle changes in diabetic patients, and the benefits of smart technology in monitoring heart health. This informative dialogue emphasizes a holistic approach to cardiovascular disease management.
undefined
Feb 21, 2023 • 21min

ASCVD Management: Making the Case for Nonstatin Therapies

Join Drs. Neha Pagidipati, Christie Ballantyne, and Gregory Piazza in a lively discussion on ASCVD management, including nonstatin therapies, challenges in patient care, and alternative treatment options. Explore the evolution towards combination therapy, considerations for statin-intolerant patients, and the importance of personalized treatment plans. Delve into the efficacy and tolerability of PCSK9 inhibitors and azetamide for statin-hesitant patients, and the benefits of combining medications to lower LDL cholesterol effectively in high-risk patients.